Literature DB >> 8037120

Documenting the value of pharmacist interventions.

R L Dobie1, K L Rascati.   

Abstract

The objectives of this study were to measure the incidence and types of pharmacist interventions performed in a community setting in two rural Texas counties; to assign some type of economic value to their services; and to compare these results with those of a previous study of interventions documented by pharmacy student externs and their preceptors. Pharmacists at four pharmacies in two Texas counties agreed to document their interventions on the next 1,500 new prescription orders brought to each pharmacy. The pharmacists first viewed a videotape training program and were instructed on the use of the Pharmacist Intervention Report. Each documented intervention was evaluated independently by a physician and a clinical pharmacist. The dollar value assigned to each of the pharmacists' interventions was the estimated direct cost of medical care avoided through the pharmacist's intervention to correct a prescribing problem. There were 47 interventions documented, representing 0.78% of the 6,000 prescription orders reviewed. The estimated value added by the interventions totaled about $20,000, or about $3.50 per prescription processed.

Mesh:

Year:  1994        PMID: 8037120     DOI: 10.1016/s0160-3450(15)30430-x

Source DB:  PubMed          Journal:  Am Pharm        ISSN: 0160-3450


  3 in total

1.  Frequency and trends of interventions of prescriptions in Flemish community pharmacies.

Authors:  Lies Leemans; Luc Veroeveren; Jef Bulens; Christiane Hendrickx; Williame Keyenberg; Frie Niesten; Jules Vandeberg; Jacques Van Hoof; Gert Laekeman
Journal:  Pharm World Sci       Date:  2003-04

2.  Evaluation results from prospective drug utilization review: Medicaid demonstrations.

Authors:  D Kidder; J Bae
Journal:  Health Care Financ Rev       Date:  1999

3.  Evaluation of medication counseling practice at community pharmacies in Qassim region, Saudi Arabia.

Authors:  Abubakr A Alfadl; Alian A Alrasheedy; Musaad S Alhassun
Journal:  Saudi Pharm J       Date:  2017-12-05       Impact factor: 4.330

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.